Clinverse, Inc. Announces Strategic Partnership with eClinical Insights - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Clinverse, Inc. Announces Strategic Partnership with eClinical Insights

Source: Company News Release

Clinverse, Inc., the new standard for automating the financial lifecycle of global clinical trials, and eClinical Insights®, a leading-edge provider of cloud-based clinical trials software, announced today they have formed a strategic partnership.

Clinverse’s ClinPay® solution automates sponsor payments to clinical vendors, investigators, and other parties throughout the entire financial lifecycle of a clinical trial, reducing workload and costs while improving transparency and control. The eClinical Insights integrated technology platform delivers real-time visibility and control across disparate systems and diverse teams, providing actionable information through in-stream clinical trial intelligence and workflow capabilities.

“Together, we are able to offer CROs and clinical trial sponsors a best-of-breed, fully integrated solution that delivers real-time visibility across the eClinical ecosystem,” said Denis Connaghan, CEO of Clinverse. “Joint customers stand to gain a measureable return on investment, increased competitive advantage, and decreased ramp-up time and learning curve.”

Using the ClinPay application programming interface (API) and eClinical Insights proprietary integration framework, the integrated solution offers seamless data integration with any other clinical technology.  With the financial lifecycle management of ClinPay and the combined trial management capabilities of eClinical Insights' TrialOps Director™ and inTrial Metrix™ applications, sponsors and CROs can further improve the performance of their clinical trials while substantially reducing labor costs associated with payment and accounting processes for clinical vendors and investigative sites.

“Adding Clinverse as a strategic partner in our integrated technology network enables us to expand the reach and capabilities of our platform,” said Peg Regan, President & CEO of eClinical Insights. “This partnership and integrated solution fit seamlessly with our philosophy and approach to improving trial performance across a complex eClinical ecosystem.”

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Company News Release,
Click here